166 related articles for article (PubMed ID: 24051699)
21. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies.
Díaz A; Valera A; Carrera C; Hakim S; Aguilera P; García A; Palou J; Puig S; Malvehy J; Alos L
Am J Surg Pathol; 2011 Nov; 35(11):1733-42. PubMed ID: 21997694
[TBL] [Abstract][Full Text] [Related]
22. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
Koch MB; Shih IM; Weiss SW; Folpe AL
Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
[TBL] [Abstract][Full Text] [Related]
23. Gene expression signature as an ancillary method in the diagnosis of desmoplastic melanoma.
Clarke LE; Pimentel JD; Zalaznick H; Wang L; Busam KJ
Hum Pathol; 2017 Dec; 70():113-120. PubMed ID: 29079183
[TBL] [Abstract][Full Text] [Related]
24. HMB45 negative spindle cell malignant melanoma.
Skelton HG; Maceira J; Smith KJ; McCarthy WF; Lupton GP; Graham JH
Am J Dermatopathol; 1997 Dec; 19(6):580-4. PubMed ID: 9415614
[TBL] [Abstract][Full Text] [Related]
25. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):506-10. PubMed ID: 23197006
[TBL] [Abstract][Full Text] [Related]
26. Desmoplastic melanoma with sarcomatoid dedifferentiation.
Kiuru M; McDermott G; Berger M; Halpern AC; Busam KJ
Am J Surg Pathol; 2014 Jun; 38(6):864-70. PubMed ID: 24618614
[TBL] [Abstract][Full Text] [Related]
27. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
Kanik AB; Yaar M; Bhawan J
J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
[TBL] [Abstract][Full Text] [Related]
28. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
[TBL] [Abstract][Full Text] [Related]
29. Concordance of somatic mutation profiles (BRAF,NRAS, and TERT) and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples.
Yang S; Leone DA; Biswas A; Deng A; Jukic D; Singh R; Sundram U; Mahalingam M
Hum Pathol; 2018 Dec; 82():206-214. PubMed ID: 30120967
[TBL] [Abstract][Full Text] [Related]
30. KIT genetic alterations in anorectal melanomas.
Santi R; Simi L; Fucci R; Paglierani M; Pepi M; Pinzani P; Merelli B; Santucci M; Botti G; Urso C; Massi D
J Clin Pathol; 2015 Feb; 68(2):130-4. PubMed ID: 25398993
[TBL] [Abstract][Full Text] [Related]
31. Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysis.
Jahn SW; Kashofer K; Halbwedl I; Winter G; El-Shabrawi-Caelen L; Mentzel T; Hoefler G; Liegl-Atzwanger B
Mod Pathol; 2015 Jul; 28(7):895-903. PubMed ID: 25769001
[TBL] [Abstract][Full Text] [Related]
32. Comment on 'A diagnostic algorithm to distinguish desmoplastic from spindle cell melanoma'.
Parsons TM
Mod Pathol; 2014 Oct; 27(10):1421. PubMed ID: 25269807
[No Abstract] [Full Text] [Related]
33. Clinicopathological features and clinical outcomes associated with TP53 and BRAF
Kim DW; Haydu LE; Joon AY; Bassett RL; Siroy AE; Tetzlaff MT; Routbort MJ; Amaria RN; Wargo JA; McQuade JL; Kemnade J; Hwu P; Woodman SE; Roszik J; Kim KB; Gershenwald JE; Lazar AJ; Davies MA
Cancer; 2017 Apr; 123(8):1372-1381. PubMed ID: 27911979
[TBL] [Abstract][Full Text] [Related]
34. BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma.
Kim J; Lazar AJ; Davies MA; Homsi J; Papadopoulos NE; Hwu WJ; Bedikian AY; Woodman SE; Patel SP; Hwu P; Kim KB
J Cutan Pathol; 2012 Sep; 39(9):821-5. PubMed ID: 22809251
[TBL] [Abstract][Full Text] [Related]
35. Melanoma hyperpigmentation is strongly associated with KIT alterations.
Wu JM; Alvarez H; García P; Rojas PL; Wong G; Maitra A; Antonescu C; Montgomery EA
Am J Dermatopathol; 2009 Oct; 31(7):619-25. PubMed ID: 19652585
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
Morgan MB; Purohit C; Anglin TR
Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
[TBL] [Abstract][Full Text] [Related]
37. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
38. Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.
Sundram U; Harvell JD; Rouse RV; Natkunam Y
Mod Pathol; 2003 Aug; 16(8):802-10. PubMed ID: 12920225
[TBL] [Abstract][Full Text] [Related]
39. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
[TBL] [Abstract][Full Text] [Related]
40. Comparison of MelanA/MART-1 and HMB45 labeling in desmoplastic melanoma.
Weissinger SE; Lennerz JK
Mod Pathol; 2014 Oct; 27(10):1421-3. PubMed ID: 25269808
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
